Skip to main content

Lab notes: Onconova completes $21M stock sale; Waypoint gets $1.7M investment

Three Philadelphia-area drug developers expanded their senior management teams.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.